Research location
Newcastle
United Kingdom
Advertisement
Research activity in Newcastle
United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 131 trials and 136 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Newcastle
131 linked trials · page 1 of 3Controlling Hyperactive Immunity With Long-lived LymphocytesNCT07473154 · 2026-04-10 · 1 site observation
RECRUITING
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.NCT07440290 · 2026-04-01 · 2 site observations
RECRUITING
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightNCT07353931 · 2026-02-09 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseNCT07174310 · 2025-11-24 · 1 site observation
RECRUITING
Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)NCT07228468 · 2025-11-18 · 1 site observation
RECRUITING
Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm Multi-stage Platform TrialNCT07207057 · 2025-09-12 · 1 site observation
RECRUITING
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationNCT06952803 · 2025-08-06 · 1 site observation
RECRUITING
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideNCT06897475 · 2025-03-28 · 1 site observation
RECRUITING
Ambroxol to Slow Progression in Parkinson DiseaseNCT05778617 · 2025-02-25 · 1 site observation
RECRUITING
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)NCT06274801 · 2024-09-03 · 1 site observation
RECRUITING
Anti-viral Action Against Type 1 Diabetes AutoimmunityNCT06452654 · 2024-05-08 · 1 site observation
RECRUITING
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.NCT07630545 · 2023-11-30 · 1 site observation
RECRUITING
IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost EffectivenessNCT07440277 · 2023-07-18 · 1 site observation
RECRUITING
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)NCT06923761 · 2023-05-21 · 1 site observation
RECRUITING
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating MutationsNCT05786716 · 2023-03-07 · 2 site observations
RECRUITING
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.NCT05768178 · 2023-03-01 · 1 site observation
RECRUITING
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial DiseaseNCT05650229 · 2022-12-13 · 1 site observation
RECRUITING
The "Global Paradise System" RegistryNCT05027685 · 2022-01-13 · 1 site observation
RECRUITING
A Study of NX-1607 in Adults With Advanced MalignanciesNCT05107674 · 2021-09-29 · 1 site observation
RECRUITING
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS RegistryNCT02071134 · 2014-03-04 · 1 site observation
RECRUITING
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseNCT07169578 · 2025-09-17 · 1 site observation
ACTIVE_NOT_RECRUITING
CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's DiseaseNCT06941779 · 2024-11-21 · 1 site observation
COMPLETED
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)NCT06383390 · 2024-04-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Patient Characteristics, Treatment Patterns and Outcomes of Patients With Severe Asthma Treated With Tezepelumab in the Real World; a Retrospective, Observational Medical Chart Review Conducted in UK Severe Asthma CentresNCT06455462 · 2024-04-22 · 1 site observation
COMPLETED
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)NCT05934526 · 2023-12-28 · 1 site observation
COMPLETED
Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer PatientsNCT06019676 · 2023-09-26 · 2 site observations
ACTIVE_NOT_RECRUITING
Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)NCT05780151 · 2023-07-10 · 1 site observation
COMPLETED
A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung CancerNCT05908734 · 2023-05-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung CancerNCT05652868 · 2023-03-23 · 1 site observation
TERMINATED
The Minuteful Kidney Test Evaluation: A Randomised Controlled TrialNCT05967312 · 2022-11-18 · 1 site observation
UNKNOWN
A Study to Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.NCT05924243 · 2022-09-22 · 1 site observation
COMPLETED
SCOOT: Sample Collection for DARTNCT05368298 · 2022-08-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple SclerosisNCT05269004 · 2022-05-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)NCT05036135 · 2021-12-02 · 1 site observation
TERMINATED
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid TumoursNCT05057013 · 2021-11-10 · 1 site observation
ACTIVE_NOT_RECRUITING
A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid ArthritisNCT04991753 · 2021-10-14 · 1 site observation
COMPLETED
Trial of Ondansetron as a Parkinson's HAllucinations TreatmentNCT04167813 · 2021-10-01 · 1 site observation
UNKNOWN
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid ArthritisNCT04871919 · 2021-05-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Severe Asthma Covid Vaccine Response StudyNCT05130320 · 2021-05-06 · 1 site observation
UNKNOWN
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's DiseaseNCT04777331 · 2021-05-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Supplementation With B. Infantis for Mitigation of Type 1 Diabetes AutoimmunityNCT04769037 · 2021-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of HyperkalaemiaNCT04864795 · 2021-04-19 · 1 site observation
COMPLETED
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)NCT04374253 · 2021-01-26 · 1 site observation
TERMINATED
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)NCT04524949 · 2020-12-29 · 1 site observation
TERMINATED
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)NCT04338022 · 2020-06-12 · 1 site observation
TERMINATED
A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)NCT04339413 · 2020-05-22 · 1 site observation
TERMINATED
CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease)NCT04226248 · 2020-01-02 · 2 site observations
COMPLETED
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor FluctuationsNCT04006210 · 2019-09-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Benralizumab Exacerbation StudyNCT04102800 · 2019-09-30 · 1 site observation
COMPLETED
Apogee InternationalNCT04065997 · 2019-09-06 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.